You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
NOVEL MINIMALLY INVASIVE METHOD TO IDENTIFY LUNG MALIGNANCIES BY MRI
SBC: 3TP IMAGING SCIENCES Topic: N/ADESCRIPTION (provided by applicant): Project Summary. The overall goal of this research program is to develop a novel magnetic resonance (MR) image analysis method that can distinguish between malignant and benign lung nodules in patients who are undergoing diagnostic evaluation for lung cancer. 3TP Imaging Sciences has developed MR image analysis software that can be used to characterize the stat ...
SBIR Phase I 2006 Department of Health and Human ServicesNational Institutes of Health -
Embedded Capability-Based Operating Systems
SBC: SICORE TECHNOLOGIES INC. Topic: SB052011Embedded systems are commonly deployed in applications where reliability is critical to operations. More recently the interest in sensor networks has added a requirement for remote access, often over openly accessible or penetrable networks. This creates a need for a defensible embedded platform whose robustness is preserved in the face of external influences ranging from nuisance disruption to ac ...
SBIR Phase II 2006 Department of DefenseDefense Advanced Research Projects Agency -
Anti-Fibrotic Therapy for Pulmonary Fibrosis
SBC: Angion Biomedica Corp. Topic: N/ADESCRIPTION (provided by applicant): Pulmonary Fibrosis is a diffuse interstitial lung disease characterized by chronic inflammation and progressive fibrosis of unknown etiology. Pulmonary fibrosis affects five million people worldwide and in the United States there are over 200,000 patients with pulmonary fibrosis. Of these more than 40,000 expire annually. Typically, patients are in their fortie ...
SBIR Phase II 2006 Department of Health and Human ServicesNational Institutes of Health -
Small Molecule Therapeutics for Myocardial Ischemia
SBC: Angion Biomedica Corp. Topic: N/ADESCRIPTION (provided by applicant): Left untreated, myocardial ischemia can lead to cardiomyocyte death and pump failure. In fact, myocardial infarction is a significant cause of morbidity and mortality in the U.S. Recent evidence suggests that scatter factor / hepatocyte growth factor, exerts direct protective effects on cardiac myocytes and can potentially be used for salvage of the ischemic my ...
SBIR Phase II 2006 Department of Health and Human ServicesNational Institutes of Health -
Novel Small Molecule Therapeutic for Spinal Cord Injury
SBC: Angion Biomedica Corp. Topic: N/ADESCRIPTION (provided by applicant): It is estimated that the annual incidence of spinal cord injury (SCI), not including those who die at the scene of the accident, is approximately 11,000 cases each year. The number of living patients in the United States as of December 2003 who have SCI, has been estimated as being approximately 243,000 persons. After initial injury, about half of those affect ...
SBIR Phase I 2006 Department of Health and Human ServicesNational Institutes of Health -
Kidney Preservation for Transplantation
SBC: Angion Biomedica Corp. Topic: N/ADESCRIPTION (provided by applicant): Renal transplantation is the most effective and cost-efficient treatment for patients in end-stage kidney failure. However ischemia-reperfusion injury, associated with the retrieval, storage and transplantation of kidneys is a major immune-independent factor adversely affecting early graft function and graft viability. Marginal donors kidneys, are even more sus ...
SBIR Phase II 2006 Department of Health and Human ServicesNational Institutes of Health -
Antithrombotic Effects of Optimized Human Apyrase
SBC: APT THERAPEUTICS, INC. Topic: N/ADESCRIPTION (provided by applicant): The goal of the proposed work is to develop a novel antithrombotic drug that is safer and more effective than current therapies. Phase I funding for this project supported the successful development of a novel expression system to facilitate efficient production and purification of an optimized human apyrase as antithrombotic agent. Under Phase II support, we w ...
SBIR Phase II 2006 Department of Health and Human ServicesNational Institutes of Health -
Intracranial Brain Function Mapping System
SBC: CHATTEN ASSOC., INC. Topic: N/ADESCRIPTION (provided by applicant): We will develop a modern, computer-controlled electrical stimulator for performing functional mapping by cortical stimulation. The primary application is for use with patients who are candidates for surgery to control or eliminate occurrence of epileptic seizures. Other applications will include functional mapping to plan surgery for other brain diseases such a ...
SBIR Phase II 2006 Department of Health and Human ServicesNational Institutes of Health -
EPP: Empirical Privilege Profiling for Black-Box Software
SBC: ATC-NY INC Topic: SB041016The Principle of Least Privilege says that programs should operate with sufficient privilege to get the job done, but no more, in order to minimize the harm that can be done in case of error. The Empirical Privilege Profiler system (EPP) will collect data about privileges actually exercised by running programs and use that data to create a composite abstract privilege profile for the program. Pr ...
SBIR Phase II 2006 Department of DefenseDefense Advanced Research Projects Agency -
Deconvolution of Spherical Aberration in Confocal Microscopy of Thick Tissues
SBC: LICKENBROCK TECHNOLOGIES, INC. Topic: N/ADESCRIPTION (provided by applicant): The confocal fluorescent microscope directly eliminates the light emitted from out-of-focus internal structures. This has enabled the observation of fluorophore-labeled processes or 3D structures deep within thick specimens. Unfortunately, high performance objective lenses are designed for immersion fluids, such as oil, glycerol, or water; the index of the spec ...
SBIR Phase I 2006 Department of Health and Human ServicesNational Institutes of Health